PMID: 40678415

FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.

Serilmez Murat, Abuelrub Anwar, Erol Ismail, Durdaği Serdar

Turkish journal of biology = Turk biyoloji dergisi · 2025

Vol. 49, Issue 3, pp. 233-246

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.